These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38385288)

  • 1. Differences in Cardiometabolic Proteins in Pregnancy Prioritize Relevant Targets of Preeclampsia.
    Lindley KJ; Perry A; Jacobs M; Petty L; Amancherla K; Zhao S; Barker C; Davila-Roman VG; Khan SS; Osmundson SS; Tanriverdi K; Freedman JE; Below J; Shah RV; Laurent LC
    Arterioscler Thromb Vasc Biol; 2024 Apr; 44(4):969-975. PubMed ID: 38385288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum amyloid A1 and pregnancy zone protein in pregnancy complications and correlation with markers of placental dysfunction.
    Fosheim IK; Jacobsen DP; Sugulle M; Alnaes-Katjavivi P; Fjeldstad HES; Ueland T; Lekva T; Staff AC
    Am J Obstet Gynecol MFM; 2023 Jan; 5(1):100794. PubMed ID: 36334725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume.
    Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D
    Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiplex Analysis of Circulating Maternal Cardiovascular Biomarkers Comparing Preeclampsia Subtypes.
    Lekva T; Sugulle M; Moe K; Redman C; Dechend R; Staff AC
    Hypertension; 2020 Jun; 75(6):1513-1522. PubMed ID: 32336238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of preeclampsia throughout gestation with maternal characteristics and biophysical and biochemical markers: a longitudinal study.
    Tarca AL; Taran A; Romero R; Jung E; Paredes C; Bhatti G; Ghita C; Chaiworapongsa T; Than NG; Hsu CD
    Am J Obstet Gynecol; 2022 Jan; 226(1):126.e1-126.e22. PubMed ID: 34998477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.
    Stepan H; Hund M; Andraczek T
    Hypertension; 2020 Apr; 75(4):918-926. PubMed ID: 32063058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expert review: preeclampsia Type I and Type II.
    Yagel S; Cohen SM; Admati I; Skarbianskis N; Solt I; Zeisel A; Beharier O; Goldman-Wohl D
    Am J Obstet Gynecol MFM; 2023 Dec; 5(12):101203. PubMed ID: 37871693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor.
    Espinoza J; Romero R; Nien JK; Gomez R; Kusanovic JP; Gonçalves LF; Medina L; Edwin S; Hassan S; Carstens M; Gonzalez R
    Am J Obstet Gynecol; 2007 Apr; 196(4):326.e1-13. PubMed ID: 17403407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences and similarities in endothelial and angiogenic profiles of preeclampsia and COVID-19 in pregnancy.
    Palomo M; Youssef L; Ramos A; Torramade-Moix S; Moreno-Castaño AB; Martinez-Sanchez J; Bonastre L; Pino M; Gomez-Ramirez P; Martin L; Garcia Mateos E; Sanchez P; Fernandez S; Crovetto F; Escolar G; Carreras E; Castro P; Gratacos E; Crispi F; Diaz-Ricart M
    Am J Obstet Gynecol; 2022 Aug; 227(2):277.e1-277.e16. PubMed ID: 35351411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.
    Rana S; Burke SD; Karumanchi SA
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S1019-S1034. PubMed ID: 33096092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks gestation.
    O'Gorman N; Wright D; Syngelaki A; Akolekar R; Wright A; Poon LC; Nicolaides KH
    Am J Obstet Gynecol; 2016 Jan; 214(1):103.e1-103.e12. PubMed ID: 26297382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preeclampsia and eclampsia: the conceptual evolution of a syndrome.
    Erez O; Romero R; Jung E; Chaemsaithong P; Bosco M; Suksai M; Gallo DM; Gotsch F
    Am J Obstet Gynecol; 2022 Feb; 226(2S):S786-S803. PubMed ID: 35177220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of new definitions of preeclampsia at term on identification of adverse maternal and perinatal outcomes.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2021 May; 224(5):518.e1-518.e11. PubMed ID: 33166504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of placental growth factor alone or in combination with soluble fms-like tyrosine kinase-1 or maternal factors in detecting preeclampsia in asymptomatic women in the second and third trimesters: a systematic review and meta-analysis.
    Chaemsaithong P; Gil MM; Chaiyasit N; Cuenca-Gomez D; Plasencia W; Rolle V; Poon LC
    Am J Obstet Gynecol; 2023 Sep; 229(3):222-247. PubMed ID: 36990308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal circulating concentrations of soluble Fas and Elabela in early- and late-onset preeclampsia.
    Para R; Romero R; Gomez-Lopez N; Tarca AL; Panaitescu B; Done B; Hsu R; Pacora P; Hsu CD
    J Matern Fetal Neonatal Med; 2022 Jan; 35(2):316-329. PubMed ID: 32008387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenic Markers and Cardiovascular Indices in the Prediction of Hypertensive Disorders of Pregnancy.
    Verlohren S; Perschel FH; Thilaganathan B; Dröge LA; Henrich W; Busjahn A; Khalil A
    Hypertension; 2017 Jun; 69(6):1192-1197. PubMed ID: 28461601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using ultrasound and angiogenic markers from a 19- to 23-week assessment to inform the subsequent diagnosis of preeclampsia.
    Lai J; Syngelaki A; Nicolaides KH; von Dadelszen P; Magee LA
    Am J Obstet Gynecol; 2022 Aug; 227(2):294.e1-294.e11. PubMed ID: 35276067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preeclampsia biomarkers: An assessment of maternal cardiometabolic health.
    Eastabrook G; Aksoy T; Bedell S; Penava D; de Vrijer B
    Pregnancy Hypertens; 2018 Jul; 13():204-213. PubMed ID: 30177053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical tools and biomarkers to predict preeclampsia.
    MacDonald TM; Walker SP; Hannan NJ; Tong S; Kaitu'u-Lino TJ
    EBioMedicine; 2022 Jan; 75():103780. PubMed ID: 34954654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenic Factors and Long-Term Cardiovascular Risk in Women That Developed Preeclampsia During Pregnancy.
    Garrido-Gimenez C; Mendoza M; Cruz-Lemini M; Galian-Gay L; Sanchez-Garcia O; Granato C; Rodriguez-Sureda V; Rodriguez-Palomares J; Carreras-Moratonas E; Cabero-Roura L; Llurba E; Alijotas-Reig J
    Hypertension; 2020 Dec; 76(6):1808-1816. PubMed ID: 33012203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.